Inhibrx Biosciences INBX
NASDAQ INBX
$90.81 -0.93 (-1.01%)
As of: Nov 10, 2026 · 2:25 PM EST

Inhibrx Biosciences (INBX) EBT Margin (2023 - 2025)

Updated

Inhibrx Biosciences (INBX) reported EBT Margin of -10773.31% for FY2025, down 854560.31 percentage points from 843787.00% in FY2024.

Analysis

Inhibrx Biosciences (INBX) EBT Margin (2023 - 2025) Analysis & Trends

  • According to Business Quant data, EBT Margin came in at 843787.00% in FY2024 (+857105.00 pp) and -13318.00% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.13%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 27.75%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.74%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 29.63%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 18.19%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 45.21%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 36.90%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 20.41%
10 Inhibrx Biosciences 1.45 Bn 882.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -2,204.00%
Dec 31, 2024 -47,865.00%
Jun 30, 2024 1,858,013.00%
Dec 31, 2023 -5,628.76%
Sep 30, 2023 -43,518.49%
Jun 30, 2023 -156,823.33%
API Access

Inhibrx Biosciences EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=INBX&period=max&api_key=YOUR_API_KEY